Neural correlates of atomoxetine improving inhibitory control and visual processing in Drug-naive adults with attention-deficit/hyperactivity disorder.

ABSTRACT: Atomoxetine improves inhibitory control and visual processing in healthy volunteers and adults with attention-deficit/hyperactivity disorder (ADHD). However, little is known about the neural correlates of these two functions after chronic treatment with atomoxetine. This study aimed to use the counting Stroop task with functional magnetic resonance imaging (fMRI) and the Cambridge Neuropsychological Test Automated Battery (CANTAB) to investigate the changes related to inhibitory control and visual processing in adults with ADHD. This study is an 8-week, placebo-controlled, double-blind, randomized clinical trial of atomoxetine in 24 drug-naïve adults with ADHD. We investigated the changes of treatment with atomoxetine compared to placebo-treated counterparts using the counting Stroop fMRI

SUBMITTER: Fan LY 

PROVIDER: S-EPMC6867141 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature